Back

Antifibrotic drugs: the journey to prime time

12 April 2026 (14:00 - 14:15)
Organised by: Logo
Congress Presentation Part of: Pharmacological treatment for atrial fibrillation Arrhythmias, General EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Shingo Matsumoto

Tokai University, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors: a new era in atrial fibrillation prevention?
Professor D. Linz (Maastricht, NL)
Slides
Presentation thumbnail
The emerging promise of GLP-1 receptor agonists
Professor V. Caso (Perugia, IT)
Slides
Presentation thumbnail
Anti-hypertensive agents: is there a benefit beyond lowering blood pressure?
Professor M. Rienstra (Groningen, NL)
Slides

Access the full session

Session thumbnail
Pharmacological treatment for atrial fibrillation

The Event

Event poster

EHRA 2026

12 April 2026 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources